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Dipeptide repeat (DPR) proteins are toxic in various
models of FTD/ALS with GGGGCC (G4C2) repeat
expansion. However, it is unclear whether nuclear
G4C2 RNA foci also induce neurotoxicity. Here, we
describe a Drosophila model expressing 160 G4C2
repeats (160R) flanked by human intronic and exonic
sequences. Spliced intronic 160R formed nuclear
G4C2 sense RNA foci in glia and neurons about ten
times more abundantly than in human neurons; how-
ever, they had little effect on global RNA processing
and neuronal survival. In contrast, highly toxic 36R in
the context of poly(A)+ mRNA were exported to the
cytoplasm, where DPR proteins were produced
at >100-fold higher level than in 160R flies. Moreover,
the modest toxicity of intronic 160R expressed at
higher temperature correlated with increased DPR
production, but not RNA foci. Thus, nuclear RNA
foci are neutral intermediates or possibly neuropro-
tective through preventing G4C2 RNA export and
subsequent DPR production.
INTRODUCTION
A GGGGCC (G4C2) repeat expansion in the noncoding region
of C9ORF72 is the most common mutation in both frontotempo-
ral dementia (FTD) and amyotrophic lateral sclerosis (ALS)
(DeJesus-Hernandez et al., 2011; Renton et al., 2011). How
G4C2 repeat expansion contributes to disease pathogenesis is
largely unknown. One potential pathogenic mechanism is medi-
ated by abnormal dipeptide repeat (DPR) proteins arising from
repeat-associated non-AUG (RAN) translation (Cleary and
Ranum, 2014). DPR proteins, synthesized from both sense and
antisense repeat transcripts and adjacent intronic sequences,
are found mostly in cytoplasmic inclusions in C9ORF72 patients
and a mouse model (Ash et al., 2013; Gendron et al., 2013; Mori
et al., 2013, 2013b; Zu et al., 2013; Chew et al., 2015). WhenNeuoverexpressed in cultured cells orDrosophila, different DPR pro-
teins have varying degrees of toxicity (Kwon et al., 2014; May
et al., 2014; Mizielinska et al., 2014; Tao et al., 2015; Wen
et al., 2014; Yang et al., 2015; Zhang et al., 2014; Zu et al., 2013).
Another potential pathogenic mechanism is RNA-mediated
toxicity, in which the formation of RNA foci and sequestration
of specific RNA-binding proteins is associated with misregula-
tion of RNA processing in repeat-expansion diseases (Mohan
et al., 2014). In the case of C9ORF72 FTD/ALS, RNA foci are
found mostly in the nucleus of multiple cell types, such as brain
cells and fibroblasts from patients and neurons derived from
induced pluripotent stem cells (iPSCs) (Almeida et al., 2013;
DeJesus-Hernandez et al., 2011; Donnelly et al., 2013; Gendron
et al., 2013; Lagier-Tourenne et al., 2013; May et al., 2014; Miz-
ielinska et al., 2014; Sareen et al., 2013; Zu et al., 2013). How-
ever, little is known about the pathogenicity of these RNA foci.
To address this question, we generated a Drosophila model
expressing in a cell-type-specific manner a C9ORF72 minigene
containing up to 160 G4C2 repeats (160R) flanked by human in-
tronic and exonic sequences. Overexpressed intronic 160R
formed abundant nuclear sense RNA foci in neurons and glial
cells but had surprisingly little toxicity in vivo. In contrast, highly
toxic 36 G4C2 repeats (36R) expressed in the context of a
poly(A)+ mRNA (Mizielinska et al., 2014) were exported to the
cytoplasm and translated into DPR proteins at a level >100-
fold higher than that by intronic 160R. Moreover, intronic 160R
expressed at a higher temperature induced a modest toxicity
that correlated with increased DPR production, but not G4C2
sense RNA foci. Thus, low levels of DPR proteins, but not nuclear
RNA foci, are a major source of toxicity in vivo.
RESULTS
The Expanded G4C2 Repeat-Containing Intron Is
Transcribed and Spliced in iPSC-Derived Human
Neurons and Patient Brain Tissues
According to the latest information in the NCBI database, at
least three splice variants of C9ORF72 are expressed in human
cells (Figure 1A). In variants 1 and 3 (V1 and V3), G4C2 repeats
are located in the first intron. In contrast, transcription of V2,ron 87, 1207–1214, September 23, 2015 ª2015 Elsevier Inc. 1207
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Figure 1. Expanded G4C2 Repeats in C9ORF72 Are Fully Transcribed in Patient Cells and Tissues
(A) Schematic of the three known transcript variants of wild-type (top) and mutant (bottom) alleles of C9ORF72, named as in PubMed and the UCSC Genome
Browser. The locations of primers used in (C) and (D) (green) and (E) and (F) (blue) are indicated.
(B) The G/A SNP in a control subject and in a carrier of expanded G4C2 repeats.
(C and D) Pyrosequencing analysis of the allele-specific expression of V3 in three C9ORF72 and three control iPSC lines (C) and in brain tissues of three patients
and three controls (D).
(E and F) The relative ratio of total V1 and V3 pre-mRNAs (exon 1–intron 1 junction) to mature mRNAs (exon 1–exon 3 junction) in cortical neurons differentiated
from four C9ORF72 and four control iPSC lines (E) and in brain tissues of eight C9ORF72 patients and nine controls (F). n.s., not statistically significant, by
Student’s t test.
(G) RNA-seq analysis reveals a significantly lower V2 level in patient neurons than control neurons. The number of reads for V1 and V3 is too low for a meaningful
analysis. ***p < 0.001, chi-square test.
See also Figure S1.whose expression level is much higher than V1 and V3 (see Fig-
ure S1 available online), starts downstream of G4C2 repeats
(Figure 1A), which has been confirmed experimentally (Sareen
et al., 2013). To quantify the effect of expanded G4C2 repeats
on the transcription and splicing of the first intron of
C9ORF72, we took advantage of a single-nucleotide polymor-
phism (SNP) in exon 3 (rs10757668) (Figure 1B), which is hetero-
zygous (A/G) in 10%–15% of the general population, with the
expanded G4C2 repeats associated with the G allele (DeJe-
sus-Hernandez et al., 2011; Sareen et al., 2013). We performed
allele-specific expression analysis of the junction between exon
1b and exon 3 in cells and brain tissues carrying the A/G SNP by
pyrosequencing, a sequence-based detection technology that
allows quantification of a sequence variation such as a SNP
(Ronaghi, 2001). We found that the ratio between G- and A-con-
taining V3 alleles was the same in iPSCs derived from three
G4C2 repeat expansion carriers and three controls (Figure 1C).1208 Neuron 87, 1207–1214, September 23, 2015 ª2015 Elsevier IncA similar result was obtained from postmortem brain tissues
(Figure 1D).
If expanded G4C2 repeats blocked the full transcription or
splicing of the first intron, one would expect that the ratio of un-
spliced RNA (as measured by the exon 1–intron 1 junction) to
maturemRNA (asmeasured by the exon 1–exon 3 junction) would
be higher. The ratio was identical in human neurons differentiated
from four C9ORF72 and four control iPSC lines (Figure 1E) and in
brain tissues from eight C9ORF72 patients and nine controls
(Figure 1F), even though the levels of both intron 1-containing
pre-mRNA and exon 1-containing mature mRNA were higher in
iPSCs-derived C9ORF72 neurons (Figure S1B) and brain tissues
(Figure S1C) than in their respective controls. Thus, the expanded
G4C2 repeats do not meaningfully affect splicing of the first intron,
andmost if not all G4C2 sense RNAs in human neurons come from
the spliced first intron of C9ORF72, consistent with our earlier
finding that intron 1-containing C9ORF72 RNA could not be.
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Figure 2. A Drosophila Model of FTD/ALS
Expressing Expanded G4C2 Repeats
(A) Schematic of human C9ORF72 minigenes
containing 5R, 80R, or 160R, flanked by human
intronic and exonic sequences. Green arrows:
primer location used in (C).
(B) Construction of DNA plasmids containing 5R,
20R, 40R, 80R, or 160R. Plasmids were digested
with EcoRI.
(C) Quantitative real-time PCR analysis of the
relative levels ofC9ORF72minigene spliced RNAs.
(D) Effect of 160R on dendritic branching of
dda neurons in third-instar larvae. No statistical
difference was observed (n > 14 flies per geno-
type).
(E) Kaplan-Meier curves showing the lifespan of
transgenic flies expressing 0, 5R, or 160R in glu-
tamatergic neurons by OK371-Gal4. No statistical
difference between 5R and 160R flies (log-rank
test).
See also Figure S2.detected by northern blot (Almeida et al., 2013). In contrast, RNA-
seq analysis revealed that mutant V2 allele (G allele) was ex-
pressed at a much lower level in patient iPSC-derived neurons
than in controls (Figure 1G), consistent with several reports
showing that the total level of V2 expressed from both alleles is
lower in C9ORF72 patient samples (Almeida et al., 2013; Belzil
et al., 2013; DeJesus-Hernandez et al., 2011; Donnelly et al.,
2013; Sareen et al., 2013; Waite et al., 2014).
A Drosophila Model of Intronic G4C2 Repeat Expansion
To investigate the pathogenicity of intronic G4C2 repeats, we de-
signed and expressed an artificial human C9ORF72 minigene in
Drosophila (Figure 2A). This minigene contains exon 1, part of the
first intron with synthetic G4C2 repeats of various lengths at the
exact same location as in human cells, and exon 3 of human
C9ORF72 (Figure 2A). DNA constructs containing uninterrupted
5, 20, 40, 80, and 160 G4C2 repeats (160R) were stable in E. coli
(Figure 2B). C9ORF72 minigenes containing 5R, 80R, and 160R
were then cloned into a transgenic fly vector (Figure 2A). The
PhiC31 integrase-mediated site-specific integration system
(Bateman et al., 2006) was used to ensure equal transcription
of minigenes with different repeat length in flies. Southern blot
analysis confirmed the repeat length of the transgenes (Fig-Neuron 87, 1207–1214, Sepure S2A). G4C2 repeats with five copies
were not detected by Southern blot but
were confirmed by PCR and sequencing
analysis. The intronic 160R remained
stable in transgenic flies over multiple
generations.
To determine whether G4C2 repeats of
different length are expressed at the
same level, we crossed 5R and 160R
transgenic flies carrying the UAS-repeat
sequences with Actin5C-Gal4 fly lines
and did quantitative real-time PCR
(qPCR) analyses. PCR analysis withprimers located in exon 1 and exon 3 revealed only a single
120 bp band corresponding to the spliced form (Figure S2B).
No difference was observed between 5R and 160R flies when
the relative level of the exon 1–exon 3 junction was quantified
by with the same set of primers (Figure 2C), suggesting that in-
tronic 160R did not affect transgene expression and splicing,
as in human cells (Figure 1).
Flies Expressing Intronic 160R Do Not Have Obvious
Neurodevelopmental Defects
C9ORF72 patients have age-dependent neurodegeneration,
but no early neurodevelopmental defects have been observed.
To determine whether flies expressing intronic 160R also
develop normally—and are thus a more physiologically faithful
model—we traced and quantified larval crawling behavior on
an agarose plate (Nichols et al., 2012). In this assay, locomotor
activity did not differ between larvae expressing 0, 5R, or 160R
driven by actin5C-Gal4 (Figure S2C). We then used Drosophila
dendritic arborization (dda) neurons as a model system (Li
et al., 2004) to study early neuronal defects that might result
from RNA toxicity. Again, no significant difference in dendritic
branching was observed (Figure 2D). Moreover, cell death
was not increased in larval brain cells expressing intronic 160Rtember 23, 2015 ª2015 Elsevier Inc. 1209
Figure 3. Overexpressed Intronic 160R Form Abundant Nuclear G4C2 Sense RNA Foci in Glia and Neurons
(A and B) The presence of multiple nuclear RNA foci (red) in glial cells (A) and glutamatergic neurons (B). The nucleus was stained with DAPI (blue) and anti-Repo
(green) for glia or anti-phospho-RNA polymerase-II for glutamatergic neurons.
(C) RNA FISH in muscle cells (top) and salivary gland cells (bottom) detects one single bright dot (red).
(D) In each salivary gland cell expressing two copies of 160R, two bright dots are present on DNA (blue) at the site of transcription.
(E) Correlation plot showing the 50 DEGs common between flies expressing 160R from the second and the third chromosomewith 45 in the same direction. Two-
fold change is designated by dashed red lines, and genes with over 2-fold change in both groups are highlighted in red. The linear regression line has a slope of
0.61, in close agreement with the relative expression levels of the transgenes in these two genetic backgrounds (Table S1).
(F) Multiple RNA foci (red) in glia do not colocalize with the nucleolus-specific marker fibrillarin (green). In all panels, red arrows indicate transgene transcription
site, and scale bars indicate 5 mm.
See also Figures S2F and S3 and Table S1, Table S2, Table S3, and Table S4.(Figure S2D). To determine whether expanded G4C2 repeats
affect the long-term viability of adult flies, we expressed intronic
5R or 160R in all cells by Actin5C-Gal4 (data not shown) or spe-
cifically in glutamatergic neurons with the OK371-Gal4 driver.
When grown at 25C, 160R flies did not show a change in their
lifespan (Figure 2E).
Overexpressed Intronic 160R Form Numerous Nuclear
Sense RNA Foci with Little Effect on rRNA Biogenesis
and mRNA Processing
Sense and antisense RNA foci are a key pathological hallmark of
C9ORF72 FTD/ALS. In iPSC-derived human neurons, most RNA
foci are nuclear although a few are cytoplasmic (Almeida et al.,1210 Neuron 87, 1207–1214, September 23, 2015 ª2015 Elsevier Inc2013). In 160R flies, no antisense foci were observed; however,
on average, 42 sense RNA foci were detected in the nucleus of
glutamatergic neurons and 49 in glia expressing intronic 160R;
no foci were observed in control flies and flies expressing 5R (Fig-
ures 3A and 3B). The average number of RNA foci per cell was
more than ten times higher than that of sense RNA foci in iPSC-
derived humanneurons (Almeida et al., 2013), probably reflecting
overexpression of G4C2 repeats by the UAS-Gal4 system.
These foci were not detected by a DNA probe targeting CUG
or CCUG repeats (data not shown) and are made of RNA, as evi-
denced by their sensitivity to RNase but not DNase treatment
(Figure S3A). In these cells, one large focus and numerous
smaller foci were invariably present (Figures 3A and 3B). The.
small foci were similar to those in human fibroblasts or iPSC-
derived neurons (Almeida et al., 2013) but distinct from G4C2 re-
peats in muscle cells or salivary gland cells (Figure 3C). Salivary
gland cells are much larger than neurons and have polytene
chromosomes. Thus, expression of intronic 160R was much
higher in this cell type; yet, very little was exported to the cyto-
plasm (Figure S3B). These large ‘‘foci’’ were always present on
chromatin and seemed to be located at the site of transgene
transcription. Indeed, they were costained with an antibody
against activated Pol-II (Figure 3B). Moreover, when two copies
of intronic 160R were expressed from two different chromo-
somes, two large dots were invariably observed in each cell (Fig-
ure 3D). Thus, signals detected at the site of transcription in
transgenic animal models should be distinguished from the
actual RNA foci observed in patient cells.
RNA foci formed by intronic 160R did not localize to the nucle-
olus or grossly alter nucleolar morphology (Figure 3F). Thus,
160R RNAs do not seem to directly impair nucleolar function.
Indeed, the level of different rRNA species did not differ between
controls and flies overexpressing 5R or 160R (Figure S3C). To
determine whether the numerous nuclear RNA foci alter mRNA
processing in flies, we sequenced the transcriptomes of male
fly heads in which a 5R or 160R transgene was ubiquitously ex-
pressed by Actin5C-Gal4. To reduce false positives caused by
the difference in genetic backgrounds and other factors, we
used flies bearing these transgenes on either the second or the
third chromosome and obtained an average of 32 million nonre-
dundant uniquely mapped reads per library (Table S1).
Gene expression in flies expressing 5R and 160R was highly
correlated (Figures S3E and S3F). Because the number of RNA
foci was comparable in flies expressing 160R from either the
second or the third chromosome (Figure S3D), we analyzed
differentially expressed genes (DEGs) from both groups and
found 50 common DEGs; 45 of them showed differential expres-
sion in the same direction (Figure 3E; Table S2). Gene ontology
analysis suggested that proteins with oxidoreductase activities
were enriched among these 45 genes (Table S3). Only 7 of these
45 genes showed a change of >2-fold. Moreover, we found only
17 exon-skipping events common to flies expressing 160R from
either the second or the third chromosome (Table S4). For
example, in the sun gene, the percent spliced in (PSI) was
16.5% in 5R flies and 22.3% in 160R flies (Figure S3G). Such a
small number of DEGs and exon-skipping changes argues
against the hypothesis that those RNA foci are capable of
sequestering sufficient RNA binding proteins to exert a global
effect on RNA processing in our fly model.
Highly Toxic 36R-Poly(A) Are Exported to the Cytoplasm,
and Intronic 160R Expressed at a Higher Temperature
Induce Modest Toxicity and Increased DPR Production
The finding that abundant nuclear G4C2 RNA foci cause little
toxicity was surprising, so we examined a fly model in which
36R are highly toxic (Mizielinska et al., 2014). This model and
another one expressing 30R (Xu et al., 2013) differ significantly
from ours, where 160R are transcribed and spliced out as part
of human intronic sequence. In those models, G4C2 repeats
are transcribed as part of a poly(A)+ mRNA. The steady-state
level of 36R-poly(A) was about 2-fold higher than that of theNeuspliced RNA in 160R flies (Figure S4B), which is likely due to their
differential posttranscriptional regulation, since both transgenes
were generated using the same site-specific integration system
and expressed by the same Gal4 driver. Nonetheless, we exam-
ined 160R homozygous flies that expressed the spliced RNA at
the same level as the 36R mRNA (Figure S4B) and found no
visible eye neurodegenerative phenotype (Figure S4C).
In flies expressing 36R-poly(A) and grown at 25C, most of the
36R-poly(A) RNA were exported to the cytoplasm of glial cells
(Figure 4A) or motor neurons (data not shown), as expected for
a poly(A)+ mRNA. Yet, in the nucleus of each cell, a bright large
dot was still observed, which we believe is the site of the trans-
gene transcription as demonstrated earlier (Figures 3B and 3D).
In stark contrast to intronic 160R, ubiquitous expression of
36R-poly(A) by Actin5C-Gal4 resulted in a developmental lethal
phenotype. Thus, to quantify DPR levels, we used GMR-Gal4 to
express these transgenes in the eye and performed a previously
described immunoassay for poly(GP) (Su et al., 2014). A similar
quantitative assay is not available for poly(GR), which is highly
toxic in flies (Mizielinska et al., 2014; Yang et al., 2015). Therefore,
we first performed immunostaining and detected poly(GR) in
both neurons and glial cells expressing 36R-poly(A), but not in
intronic 160R (Figures 4B and S4A). Similarly, the poly(GP) level
was >100-fold higher in flies expressing 36R-poly(A) than in in-
tronic 160R (Figure 4C). The high level of DPRproteins, especially
poly(GR) produced from 36R-poly(A), correlates well with the
eye-degenerativephenotype (FigureS4C)and the increased level
of p62 (Figure S4D). Thus, the toxicity of expanded G4C2 repeats
is greatly influenced by their subcellular location.
In contrast to flies grown at 25C (Figure 2E), intronic 160R
expression at 29C induced a modest toxicity as measured by
the lifespan assay (Figure 4D). The number of RNA foci in both
neurons and glial cells remained the same (Figure 4E). However,
DPR production was 4-fold higher in 160R flies grown at 29C
than at 25C (Figure 4F). These findings suggest that intronic
160R expressed at a higher temperature inducesmodest toxicity
through increased DPR production, further supporting the notion
that low levels of DPR proteins, but not nuclear sense RNA foci,
are a major source of toxicity in our fly model.
DISCUSSION
In this study, we established a Drosophila model in which 160R
were flanked by human intronic and exonic sequences, and tran-
scribed and spliced in vivo. We first confirmed that expanded
G4C2 repeats, some of them containing more than 1,000 copies
(Almeida et al., 2013), are transcribed and spliced as part of the
first intron of C9ORF72 in human cells and patient brain tissues.
This finding was not unexpected, as the highly evolved human
transcription machinery contains multiple factors to perform
this complex reaction in vivo (Shilatifard et al., 2003), in contrast
to an observed high level of aborted transcription by bacterio-
phage T7 polymerase alone in an in vitro assay with short G4C2
repeats (Haeusler et al., 2014). Some transcription elongation
factors, such as Supt4h, facilitate transcription through long
repeat sequences in human cells (Liu et al., 2012).
In general, most spliced introns stay in the nucleus, although
some are exported to the cytoplasm (Hesselberth, 2013).ron 87, 1207–1214, September 23, 2015 ª2015 Elsevier Inc. 1211
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Figure 4. Increased DPR Production, but Not Nuclear RNA Foci, Contributes to Repeat Toxicity In Vivo
(A) RNA FISH in glial cells detects numerous nuclear RNA foci (red) formed by intronic 160R, while 36R-poly(A) RNA is exported to the cytoplasm. Green, nuclear
membrane; blue, DAPI staining. Red arrows, transcription sites of transgenes. Scale bar, 5 mm.
(B) Poly(GR) (red) was detected mostly in the cytoplasm of neurons expressing 36R-poly(A), but not in cells expressing intronic 160R. Scale bar, 5 mm.
(C) One of the two experiments to measure poly(GP) in lysates from heads of flies raised at 25C. Values are mean ± SEM. ***p < 0.0001 (one-way ANOVA). On
average, the poly(GP) level is 122 times higher in 160R flies than in 36R flies.
(D) The lifespan of transgenic flies grown at 29C expressing 0, 5R, or 160R in glutamatergic neurons. Statistical difference between 5R and 160R flies was
assessed with the log-rank test (p < 0.001).
(E) Quantification of nuclear RNA foci in neurons and glia in flies grown at 25C and 29C. No statistical difference was observed (by unpaired nonparametric
t test).
(F) Poly(GP) levels in lysates from heads of flies raised at 25C and 29C. Values are mean ± SEM. ***p < 0.0001 (one-way ANOVA).
See also Figure S4.Indeed, intronic 160R formed abundant nuclear G4C2 RNA foci in
both neurons and glia with only a few foci outside of the nucleus.
The average number of these nuclear RNA foci was more than
ten times higher than we observed in iPSC-derived neurons (Al-
meida et al., 2013). However, the transciptome was largely unaf-1212 Neuron 87, 1207–1214, September 23, 2015 ª2015 Elsevier Incfected, rRNA biogenesis was not significantly altered, and nucle-
olar morphology appeared to be normal. Thus, these foci by
themselves do not elicit significant toxicity, at least in this exper-
imental system. Our results comparing flies grown at 25C
versus 29C also support the notion that nuclear G4C2 sense.
RNA foci are not a significant source of toxicity. Whether
more abundant antisense foci are neurotoxic remains to be
determined.
DPR proteins are mostly found in cytoplasmic inclusions of
postmortem brain tissues of C9ORF72 patients and a mouse
model (Ash et al., 2013; Gendron et al., 2013; Mori et al., 2013;
Zu et al., 2013; Chew et al., 2015). We speculate that they are
produced from either intronic repeat RNAs and/or unspliced
C9ORF72 pre-mRNAs that are transported to the cytoplasm.
The poly(A) tail facilitates nuclear export and cytoplasmic trans-
lation of mature mRNAs (Weill et al., 2012). Indeed, we found that
36R expressed in the context of poly(A)+mRNAwere exported to
the cytoplasm and produced DPRs at a level >100-fold higher
than that in 160R flies (Figure 4C).
Many animal models fail to fully recapitulate human neurode-
generativediseases, becauseaging is amajor risk factor for these
disorders. During aging, a subset of nucleoporins is oxidatively
damaged, resulting in increased nuclear permeability (D’Angelo
et al., 2009). Thus, aging itself or environmental stressmay cause
increased leakage of expanded G4C2 repeats in an intron or an
unspliced pre-mRNA into the cytoplasm, resulting in increased
production of toxic DPRs in some vulnerable human neurons.
DPR proteins of various lengthsmay have different pathogenic
mechanisms.We recently found that, in contrast to (GR)20 (Kwon
et al., 2014), (GR)80 is located mostly in the cytoplasm and
impairs the Notch signaling pathway, whereas (GA)80 recruits
(GR)80 into cytoplasmic inclusions, thereby decreasing (GR)80
toxicity (Yang et al., 2015). Moreover, poly(GR) proteins of
different length used in different studies can either directly or
indirectly induce nucleolar stress (Kwon et al., 2014; Wen
et al., 2014; Yang et al., 2015). Thus, much remains to be learned
about the pathogenic mechanisms of DPR proteins of different
lengths. Although the lifelong presence of sense RNA foci in
the nucleus might still be detrimental, our results suggest that
they could also be neutral intermediates or even neuroprotective
by sequestering G4C2 repeats in the nucleus and therefore
preventing cytoplasmic DPR production. Thus, inhibition of
the toxicity of DPR proteins, especially nonaggregated forms,
seems to represent a more promising therapeutic approach for
C9OFR72 patients.
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